The Bridge Digital Talk #28 – Richard Johnsson
What is positive about developing a vaccine under time pressure? What is negative?
Are we better prepared for future pandemics thanks to the lessons we learned from the Covid-19 pandemic?
In The Bridge Talk on Dec 11, Richard Johnsson, Head of peptide chemistry at Red Glead Discovery and associate professor in organic chemistry, will answer these questions, and any other questions you have about the ongoing Covid-19 vaccine development. Red Glead Discovery is contributing with the active parts (the peptides) in one of the ongoing Covid-19 vaccine projects, Immunova.
Register in the Facebook event and get all the information. See you on the 11th!